M. R. Moore

2.2k total citations
49 papers, 1.5k citations indexed

About

M. R. Moore is a scholar working on Molecular Biology, Pediatrics, Perinatology and Child Health and Health, Toxicology and Mutagenesis. According to data from OpenAlex, M. R. Moore has authored 49 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Molecular Biology, 13 papers in Pediatrics, Perinatology and Child Health and 13 papers in Health, Toxicology and Mutagenesis. Recurrent topics in M. R. Moore's work include Porphyrin Metabolism and Disorders (22 papers), Heme Oxygenase-1 and Carbon Monoxide (15 papers) and Heavy Metal Exposure and Toxicity (13 papers). M. R. Moore is often cited by papers focused on Porphyrin Metabolism and Disorders (22 papers), Heme Oxygenase-1 and Carbon Monoxide (15 papers) and Heavy Metal Exposure and Toxicity (13 papers). M. R. Moore collaborates with scholars based in United Kingdom, United States and Canada. M. R. Moore's co-authors include A. Goldberg, A. D. Beattie, Harold S. Zarkowsky, G G Thompson, Julian A. T. Dow, C. MacDonald, J. McGadey, Philip Payne, K E McColl and Geoff Thompson and has published in prestigious journals such as Nature, The Lancet and The Science of The Total Environment.

In The Last Decade

M. R. Moore

48 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
M. R. Moore United Kingdom 24 619 423 225 214 181 49 1.5k
William J. George United States 25 586 0.9× 341 0.8× 142 0.6× 138 0.6× 119 0.7× 72 1.9k
Jordi To‐Figueras Spain 26 870 1.4× 720 1.7× 194 0.9× 100 0.5× 138 0.8× 89 2.1k
Subbarao V. Kala United States 20 612 1.0× 367 0.9× 99 0.4× 202 0.9× 46 0.3× 28 1.6k
Nachman Gruener Israel 21 451 0.7× 205 0.5× 131 0.6× 80 0.4× 75 0.4× 60 1.6k
Birgitta Hæger-Aronsen Sweden 19 597 1.0× 395 0.9× 137 0.6× 262 1.2× 91 0.5× 48 1.1k
Yoon Hee Cho United States 27 703 1.1× 697 1.6× 281 1.2× 138 0.6× 110 0.6× 82 2.0k
Jacint Corbella i Corbella Spain 24 393 0.6× 412 1.0× 128 0.6× 304 1.4× 65 0.4× 96 1.5k
D Barltrop United Kingdom 23 143 0.2× 763 1.8× 118 0.5× 574 2.7× 288 1.6× 70 1.6k
Chunfang Zhu China 25 484 0.8× 342 0.8× 285 1.3× 224 1.0× 75 0.4× 70 1.9k
Luke C. Carey United States 12 237 0.4× 609 1.4× 212 0.9× 806 3.8× 96 0.5× 35 1.5k

Countries citing papers authored by M. R. Moore

Since Specialization
Citations

This map shows the geographic impact of M. R. Moore's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. R. Moore with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. R. Moore more than expected).

Fields of papers citing papers by M. R. Moore

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M. R. Moore. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. R. Moore. The network helps show where M. R. Moore may publish in the future.

Co-authorship network of co-authors of M. R. Moore

This figure shows the co-authorship network connecting the top 25 collaborators of M. R. Moore. A scholar is included among the top collaborators of M. R. Moore based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M. R. Moore. M. R. Moore is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Smythe, Lee D., Hume Field, Leonie J. Barnett, et al.. (2002). Leptospiral Antibodies in Flying Foxes in Australia. Journal of Wildlife Diseases. 38(1). 182–186. 45 indexed citations
2.
Ng, J. C., A. A. Seawright, B. Chiswell, & M. R. Moore. (1998). Tumours in C57BI/6J and metallothionein knock-out transgenic mice induced by chronic arsenic exposure over two years. Toxicology Letters. 95. 183–183. 2 indexed citations
3.
Graziano, Joseph H., Conrad B. Blum, Nancy J. Lolacono, et al.. (1996). A human in vivo model for the determination of lead bioavailability using stable isotope dilution.. Environmental Health Perspectives. 104(2). 176–179. 24 indexed citations
4.
Lanyon, W. George, et al.. (1993). Evidence for involvement of a second genetic locus on chromosome 11q in porphyrin metabolism. Human Genetics. 91(6). 576–8. 7 indexed citations
5.
Lip, Gregory Y.H., K E McColl, & M. R. Moore. (1993). THE ACUTE PORPHYRIAS. International Journal of Clinical Practice. 47(1). 38–43. 8 indexed citations
6.
Taylor, D.J., B Rajagopalan, G. K. Radda, et al.. (1990). Phosphorus magnetic resonance spectroscopy studies of acute intermittent porphyria. Molecular Aspects of Medicine. 11. 56–58. 1 indexed citations
7.
Cutler, Margaret G., Johannes Mair, & M. R. Moore. (1990). Pharmacological activities of delta‐aminolaevulinic acid, protoporphyrin IX and haemin in isolated preparations of rabbit gastric fundus and jejunum. Journal of Autonomic Pharmacology. 10(2). 119–126. 2 indexed citations
8.
Moore, M. R., et al.. (1990). The porphyrias. Blood Reviews. 4(2). 88–96. 15 indexed citations
9.
Moore, M. R., S R Garfin, & Alan R. Hargens. (1988). Wide Tourniquets Eliminate Blood Flow at Low Inflation Pressures. Survey of Anesthesiology. XXXII(4). 223–223. 2 indexed citations
10.
McColl, Kenneth E.L., et al.. (1986). Chester porphyria: a clinical study of a new form of acute porphyria.. BMJ. 292(6518). 455–459. 14 indexed citations
11.
Moore, M. R., et al.. (1985). CHESTER PORPHYRIA: BIOCHEMICAL STUDIES OF A NEW FORM OF ACUTE PORPHYRIA. The Lancet. 326(8459). 796–799. 27 indexed citations
12.
Meissner, P.N., Edward D. Sturrock, M. R. Moore, Peter Disler, & Dennis Maeder. (1985). Protoporphyrinogen oxidase, porphobilinogen deaminase and uroporphyrinogen decarboxylase in variegate porphyria. Biochemical Society Transactions. 13(1). 203–204. 4 indexed citations
13.
Spike, R.C., H. S. Johnston, J. McGadey, et al.. (1985). Quantitative studies on the effects of hormones on structure and porphyrin biosynthesis in the Harderian gland of the female golden hamster: I. The effects of ovariectomy and nitrogen administration.. PubMed. 142. 59–72. 46 indexed citations
14.
McColl, K E, Andrew Wallace, M. R. Moore, G G Thompson, & A. Goldberg. (1982). Alterations in Haem Biosynthesis during the Human Menstrual Cycle: Studies in Normal Subjects and Patients with Latent and Active Acute Intermittent Porphyria. Clinical Science. 62(2). 183–191. 32 indexed citations
15.
McColl, K E, M. R. Moore, G G Thompson, & A. Goldberg. (1981). Treatment with Haematin in Acute Hepatic Porphyria. QJM. 50(198). 161–74. 49 indexed citations
16.
Moore, M. R., et al.. (1979). PRENATAL AND POSTNATAL MATERNAL LEUCOCYTE ASCORBIC ACID CONCENTRATIONS. BJOG An International Journal of Obstetrics & Gynaecology. 86(4). 293–298. 2 indexed citations
17.
Campbell, Brian C., et al.. (1977). Renal insufficiency associated with excessive lead exposure.. BMJ. 1(6059). 482–485. 48 indexed citations
18.
Moore, M. R., et al.. (1977). A RETROSPECTIVE ANALYSIS OF BLOOD-LEAD IN MENTALLY RETARDED CHILDREN. The Lancet. 309(8014). 717–719. 59 indexed citations
19.
Beattie, A. D., et al.. (1973). Acute Intermittent Porphyria: Response of Tachycardia and Hypertension to Propranolol. BMJ. 3(5874). 257–260. 17 indexed citations
20.
Beattie, A. D., et al.. (1972). Environmental Lead Pollution in an Urban Soft-water Area. BMJ. 2(5812). 491–493. 84 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026